DRREDDY's weekly return of 2.94% was a moderate performance, with a Sharpe Ratio of 0.91 indicating a relatively good balance between return and risk. The stock's volatility of 12.75% was relatively low compared to its peers. While it underperformed DIVISLAB, it outperformed SUNPHARMA and HINDUNILVR. Overall, the stock's risk profile was moderate this week.

[Volatility: 12.75%]